Pharmacogenomics—Clinical and Social Implications

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|33|3|224-227

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.33, Iss.3, 2003-09, pp. : 224-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Implications of the incidentalome for clinical pharmacogenomics

By Brothers Kyle B   Langanke Martin   Erdmann Pia  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1353-1362

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike   Tran Agnès   Rey Elisabeth   Pons Gérard   Tréluyer Jean-Marc  

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics

By McLeod Howard L   Siva Chokkalingam  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics: implications and considerations for pharmacists

By Brock Tina Penick   Valgus John M   Smith Scott R   Summers Kelly M  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 321-330

Future Medicine

Access to resources Recommend Favorite

The genetics of aging – implications for pharmacogenomics

By Perls Thomas   Puca Annibale  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 469-484

Future Medicine

Access to resources Recommend Favorite